2nd Quarter - Report

ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.

Firm
Client
Income
—
Expenses
$188,925
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Russia PNTR legislation

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Medical device tax repeal - HR 436

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 436 (112th)

Health Issues HCR

Medical device user fee reauthorization legislation - FDA Safety and Innovation Act, including custom device provision of the act

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.